Tabla de Contenidos: “…METABOLITOS AISLADOS DEL HONGO TRAMETES (...) -- 1.7. LEISHMANIÁSIS, ENFERMEDAD TROPICAL (...) -- 1.7.1. MANIFESTACIONES DE LA LEISHMÁNIASIS (...) -- 1.7.2. …”

Tabla de Contenidos: “…Capítulo 55 - Fibroma laxo o péndulo -- Capítulo 56 - Granuloma piógeno -- Capítulo 57 - Hemangiomas -- Capítulo 58 - Milium -- Capítulo 59 - Molusco contagioso -- Capítulo 60 - Queloide -- Capítulo 61 - Queratoacantoma -- Capítulo 62 - Queratosis seborreica -- Capítulo 63 - Quiste de inclusión epidérmica -- Capítulo 64 - Verruga vulgar -- Capítulo 65 - Xantelasma -- Capítulo 66 - Xantomas -- Capítulo 67 - Carcinoma basocelular -- Capítulo 68 - Carcinoma espinocelular -- Capítulo 69 - Enfermedad de Paget (mamaria y extramamaria) -- Capítulo 70 - Linfomas -- Capítulo 71 - Melanoma maligno -- Capítulo 72 - Metástasis cutáneas -- Capítulo 73 - Nevus -- Capítulo 74 - Enfermedades del pelo y cuero cabelludo -- Capítulo 75 - Enfermedades de las uñas -- Capítulo 76 - Enfermedades vésico ampollosas -- Capítulo 77 - Leishmaniasis en las américas -- Capítulo 78 - Micosis subcutáneas -- Capítulo 79 - Tuberculosis cutánea -- Capítulo 80 - Enfermedades de transmisión sexual (ETS) -- Capítulo 81 - Colagenosis -- Capítulo 82 - Genodermatosis -- Capítulo 83 - Manifestaciones cutáneas de las enfermedades sistémicas -- Capítulo 84 - Vasculitis y púrpura -- Capítulo 85 - Úlceras de los miembros inferiores -- Capítulo 86 - Dermatología pediátrica -- Capítulo 87 - Dermatología geriátrica -- Capítulo 88 - Cirugía dermatológica -- Capítulo 89 - Terapéutica dermatológica -- Capítulo 90 - Iatrogenia en dermatología -- Capítulo 91 - SIDA y enfermedad cutánea -- Capítulo 92 - Diccionario dermatológico -- Distribuidores Fondo Editorial CIB…”

Tabla de Contenidos: “…EMERGING INFECTIOUS DISEASES FROM THE GLOBAL TO THE LOCAL PERSPECTIVE -- Copyright -- REVIEWERS -- Preface -- ABOUT THE WORKSHOP -- ORGANIZATION OF WORKSHOP SUMMARY -- ACKNOWLEDGMENTS -- Contents -- Summary and Assessment -- EMERGING INFECTIONS: THE GLOBAL PICTURE -- Financial Costs of Infectious Diseases -- Infectious Diseases and Human Rights -- FACTORS IN EMERGENCE OF INFECTIOUS DISEASES -- Global Trade and Travel -- Seasonality and Climate Variation -- Zoonoses -- Food Safety -- Antimicrobial Drug Use in Animals and Humans -- Slowed Vaccine and Drug Development and Degraded Immunization Policies -- NEED FOR COORDINATION AND COLLABORATION -- Cooperation Across Borders -- Bilateral Agreements -- International Health Regulations -- NETWORKS OF GLOBAL SURVEILLANCE -- Continuing Need for Local Surveillance -- Preservation of Samples -- Using the Internet for Reporting and Communication -- TAKING ADVANTAGE OF WINDOWS OF OPPORTUNITY -- 1 Introduction -- LOST WINDOWS OF OPPORTUNITY -- GLOBAL RESPONSES TO EMERGING INFECTIONS -- WINDOWS OF OPPORTUNITY FOR THE FUTURE -- 2 Emerging Infections in Latin America -- OVERVIEW -- EMERGING INFECTIONS IN COLOMBIA: A NATIONAL PERSPECTIVE -- Environmental Changes -- Human Demographics, Mosquito Behavior, and Deforestation -- Emerging Antimicrobial Resistance -- Complacency and Natural Disasters -- Conclusion -- A NATIONAL STRATEGY FOR EMERGING INFECTIOUS DISEASES: THE ARGENTINE CASE OF 1999 -- Argentine Hemorrhagic Fever -- HIV/AIDS -- Leishmaniasis -- Cholera Epidemic -- Hemolytic-Uremic Syndrome -- Bacterial Antibiotic Resistance -- Multidrug Tuberculosis Resistance -- Hantavirus Pulmonary Syndrome -- Dengue -- Bilateral and Multilateral Agreements -- DIAGNOSIS, EPIDEMIOLOGICAL SURVEILLANCE, AND CONTROL PROGRAMS FOR EMERGING AND RE-EMERGING INFECTIOUS DISEASES IN MEXICO -- Dengue -- Leptospirosis -- Tuberculosis…”

Tabla de Contenidos: “…Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections -- 51. …”

“…Large numbers of people suffer from diseases like malaria, dengue, filariasis and leishmaniasis, especially in the tropics. Whereas these diseases were eradicated from the temperate climate zones, in recent years the rising incidence of 'emerging' vector-borne diseases such as bluetongue, West Nile Virus, Lyme disease, tick-borne encephalitis and the recent outbreaks of chikungunya and dengue in southern Europe provide evidence that these diseases are resilient and can disperse to other regions and continents where before they were not present or relevant. …”

Tabla de Contenidos: “…6.4 Tuberculosis -- 6.5 Hepatitis B and C -- 6.6 Malaria -- 6.7 Buruli ulcer -- 6.8 Leishmaniasis -- 6.9 Cervical cancer -- 6.10 Noncommunicable diseases -- 6.11 Mental health among people living with HIV -- 6.12 Drug use -- 6.13 Sexually transmitted infections -- 6.14 Vaccines for people living with HIV -- 6.15 HIV-related skin and oral conditions -- 6.16 Nutritional care and support -- 6.17 Palliative care -- 6.18 Noncommunicable diseases among children and adolescents -- SERVICE DELIVERY -- 7.1 Introduction -- 7.2 Linkage from HIV testing to enrolment in care -- 7.3 Differentiated service delivery for HIV treatment -- 7.4 People-centred care -- 7.5 Initiating and maintaining treatment -- 7.6 Continuity of care -- 7.7 Task sharing -- 7.8 Decentralization -- 7.9 Integrating services -- 7.10 Delivering HIV services to children -- 7.11 Service delivery for adolescents -- 7.12 Improving the quality of HIV care services -- 7.13 Procurement and supply management systems for HIV health products -- 7.14 Laboratory and diagnostic services -- 7.15 Laboratory connectivity -- MONITORING ART PROGRAMME FUNCTIONING -- 8.1 Introduction -- 8.2 Selection of key indicators to improve service delivery and assess impact -- 8.3 Data collection and disaggregation -- 8.4 Strengthening data systems -- 8.5 Evaluation, including impact and programme performance -- 8.6 Monitoring ARV drug toxicity -- 8.7 HIV drug resistance -- Publication, dissemination and evaluation -- 9.1 Publication -- 9.2 Dissemination and implementation -- 9.3 Useful analytical tools for planning -- 9.4 Evaluation -- Glossary -- ANNEX 1: DOSAGES FOR ARV DRUGS -- Annex 2: key drug interactions -- for aRVs -- 1.1 Background and rationale -- 1.2 Objectives -- 1.3 Target audience -- 1.4 Guiding principles -- 1.5 Methods for developing the guidelines -- 1.6 Organization of the guidelines…”

Tabla de Contenidos: “…DRACUNCULIASIS (GUINEA WORM) -- Dracunculiasis in Children and Adolescents -- Dracunculiasis in Adult Females -- ONCHOCERCIASIS AND LYMPHATIC FILARIASIS -- Onchocerciasis in Children -- Onchocerciasis in Adolescents -- Onchocerciasis in Adult Females -- LEISHMANIASIS AND LEPROSY -- CONCLUSIONS -- RESEARCH NEEDS -- References -- 11 Sexually Transmitted Diseases and HIV Infection -- OVERVIEW -- STDs, Including HIV Infection, and their Complications -- Complications of STDs -- Gender Differentials in STDs and HIV Infection -- Control Over the Circumstances of Sexual Intercourse -- Acquisition of STDs and HIV Infection and Development of Complications -- Health-Seeking Behavior -- Detection and Treatment of STDs -- The Social Implications of STDs and HIV Infection -- STDs and HIV Infection Throughout the Female Life Span -- Infancy, Childhood, and Adolescence -- MAGNITUDE OF THE PROBLEM -- Morbidity -- Prevalence -- Mortality -- Economic Impact -- SOCIETAL DETERMINANTS OF STDS AND HIV INFECTION -- Population-Age Composition -- Urbanization, Sex Ratio, and Population Mobility -- War and Social Unrest -- Sexual Norms, Women's Social Status, and Patterns of Sexual Behavior -- Availability and Utilization of Health Services -- CONCLUSIONS -- RESEARCH NEEDS -- Operational Research -- Technology Development -- Behavioral Research -- Clinical Research and Epidemiology -- Notes -- References -- APPENDIX -- Appendix A Demographic Overview and State of the Data -- DATA ON FEMALE MORTALITY AND MORBIDITY ACROSS THE LIFE SPAN -- Data on Mortality -- Sources and Measures -- Gender Differences in Mortality -- Levels of Mortality -- Trends in Mortality over Time -- Cause-Specific Mortality Across the Life Span -- Data on Morbidity -- Sources and Quality -- Estimates of Morbidity -- Disability-Adjusted Life Years…”

Tabla de Contenidos: “…LOBOMICOSIS (LACAZIOSIS) -- AGENTE ETIOLÓGICO -- MODO DE TRANSMISIÓN -- PATOGÉNESIS Y ENFERMEDAD -- MANIFESTACIONES CLÍNICAS -- DIAGNÓSTICO -- EPIDEMIOLOGÍA, PREVENCIÓN Y CONTROL -- TRATAMIENTO -- BIBLIOGRAFÍA -- 21. LEISHMANIASIS -- AGENTES ETIOLÓGICOS -- MODO DE TRANSMISIÓN -- PATOGÉNESIS Y ENFERMEDAD -- MANIFESTACIONES CLÍNICAS -- DIAGNÓSTICO -- EPIDEMIOLOGÍA, CONTROL Y PREVENCIÓN -- TRATAMIENTO -- BIBLIOGRAFÍA -- 22. …”

“…Some pentavalent antimony compounds are used to treat leishmaniasis. Workers can be exposed during smelting, manufacture of antimony compounds, glass, textiles, and batteries, and electrical-waste processing. …”